Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: business – Page 260

Over the past half year, bots have been a widely discussed topic. Experts and the media heavily discussed all the possible benefits, the future, and the value bots could create for businesses and consumers. Arguably, the tipping point was Facebook’s F8 conference in April. Since then, many developers and consumers have massively experimented with bots and tested their limits to find the most suitable use cases for bots.

During this trend, the U.S. market has proven to be highly interested in bots. Several published surveys are showing strong U.S. bot companies, as you can see in VentureBeat’s Bots Landscape. But Europe is not far behind.

Read more

As the world’s political and business leaders gathered at Davos, it fell to a professor from the University of Bristol to reveal to them the full implications of a ‘fourth industrial revolution’.

Professor Jeremy O’Brien, director of the Centre for Quantum Photonics at the University of Bristol, addressed some of the most powerful people in the world yesterday at the annual meeting of the World Economic Forum (WEF) in Davos, Switzerland – to tell them just how rapidly quantum computers could change the world.

Part of the European Research Council (ERC) Ideas Lab delegation, Professor O’Brien has been actively involved with the WEF over the past few years and recently took on the role of co-chair of the Global Future Council on Computing. Last year he presented a talk on working towards a quantum computer discussing the future of computing and how new fields of computer sciences are paving the way for the next digital revolution.

Read more

Interesting approach.

Families who rely on food stamps may not be left out of the future of grocery shopping after all.

The pilot, which will run for two years, will launch on Shop.safeway.com in August.

The other retailers include Amazon, testing the program in New York, New Jersey and Maryland; Safeway, testing it in Maryland, Oregon and Washington; delivery service FreshDirect, testing in New York; and other regional and local grocers testing the program in New York and other East Coast states. As with the core program, SNAP participants will be able to use their benefits only to purchase eligible items online, not to pay for service or delivery charges. “Allowing consumers to use their SNAP benefits in the same way you would also use a credit or debit card to purchase groceries will lead to lower prices and greater options for consumers in every corner of this city and state”, said Diaz “I want to thank Congressman Maloney and our NY delegation, our partners in business and the health and hunger advocates who understood the need for this pilot program and joined our efforts to bring this important new program to NY”. “With the SNAP Pilot, we look forward to bringing the online purchasing option to SNAP clients and positively impacting all the communities that we serve”.

Continue reading “Government testing online grocery shopping for food stamp participants” | >

QC in the mainstream is definitely viable less than 7 yrs. and possible within 5 yrs. However, I have a friend who even believes we’re looking at 3 years.

Internet security, once considered to be strictly in the domain of the wonkiest tech experts, has become central to public discourse over the past year. Besides the attacks on the DNC, even tech savvy business like Snapchat, Oracle and Verizon Enterprise Solutions have had significant breaches in the last year.

For the most part, these attacks were preventable. Often, hackers use a technique called social engineering, to trick people into allowing them into a system. Other times, they exploit a vulnerability in software to give them access to confidential data. In most cases, more stringent procedures can prevent attacks.

However, there is a more serious crisis coming. In five to ten years, we are likely to see quantum computers that are so powerful that they are able to break even the strongest encryption in use today. That means that soon, even our most vital and well protected data will be at risk. So if you want to protect your businesses, you should start preparing now.

Continue reading “The Future Of Encryption” | >

Nice.

Synthetic RNA kit business Synthego has raised $41 million to step up its efforts to make CRISPR gene editing easier and more accurate. The West Coast startup relied heavily on tech VCs for the cash, but also gained validation from having CRISPR pioneer Jennifer Doudna invest in its business.

Redwood City, CA-based Synthego exited stealth in August, four years after it was set up by two former SpaceX computer engineers. In those early years, which were bankrolled by an $8.3 million investment in 2013, Synthego established an automated manufacturing process for guide RNA products that it thinks sets it apart from larger competitors in terms of cost, turnaround time and editing efficiency.

Sythengo has persuaded some big names it is on to something. 8VC, an infrastructure-focused VC that also invested in uBiome, led the round with support from fellow new backers AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Equities and ZhenFund. Existing investors including Peter Thiel’s Founders Fund and Menlo Ventures also contributed to the Series B round.

Read more

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, announced the commercial approval of naturally derived Bioquantine food ingredients in the Eurasian Customs Union (formerly known as the Customs Union of Belarus, Kazakhstan, and Russia). Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, collaborated with Bioquark Inc. on the regulatory approvals.

green-cell

“We are very excited about this successful regulatory approval,” said Ira S. Pastor, CEO, Bioquark Inc. “The commercialization of Bioquantine food ingredients, including functional foods, drinks, and dietary supplements, represents another important step in our continued evolution as a company focused on a broad range of products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

gene-sequencing

The integration of a complex set of newer research disciplines, including interkingdom signaling, semiochemical communication, and evolutionary biology, as well as significant recent activity in the areas of the microbiome and virome, are highlighting a myriad of new ways that non-human bio-products can affect the human genome for positive transitions in health and wellness dynamics.

“Bioquark has spent several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival,” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This Eurasian initiative is one more step in the path in allowing humans to recapture these capabilities to effectively counter our unfortunate progression into aging, disease and degeneration.”

bqaproduction

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

Link to Press — http://www.prweb.com/releases/2017/01/prweb13955162.htm

There is no written rule-book to follow when it comes to career survival. The “Future of Work” is about making ourselves employable in a workforce where the priority of business leaders is to invest in automation and digital technology, more than training and developing their own workforces.

As our soon-to-be-released State of Operations and Outsourcing 2017 study, conducted in conjunction with KPMG across 454 major enterprise buyers globally, shows a dramatic shift in priorities from senior managers (SVPs and above), where 43% are earmarking significant investment in robotic automation of processes, compared with only 28% placing a similar emphasis on training and change management. In fact, the same number of senior managers are as focused on cognitive computing as their own people … yes, folks, this is the singularity of enterprise operations, where cognitive computing now equals employees’ brains when it comes to investment!

Read more

For a few lucky patients, 2016 was the year when gene therapy turned from promises to cures. The technology, long contemplated as a way to erase disease by revising people’s DNA, made big advances and began turning into a real business offering some of the world’s most expensive and revolutionary medicines.

So what is gene therapy, anyway? The US Food and Drug Administration says it’s any treatment in which a replacement gene is added to a person’s body or a disease-causing one is inactivated. That’s usually done by adding­­­­­­ new instructions to cells via billions of viruses stuffed with correct DNA strands.

It sounds complicated, and it is. Gene therapy was first tested in a person in 1990, but scary side effects turned the gene-fix idea into a scientific backwater. And the field hasn’t conquered all its problems. We started the year with the tale of Glybera, heralded as the first gene treatment ever approved that sought to correct an inherited gene error. Yet the drug came with an eye-popping price tag of $1 million and, dogged by questions over how well it works, has turned into a medical and commercial flop.

Read more